⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 8, 2026

Sumatriptan 1A Pharma 50 mg - Tabletten 50 mg (Tablette)

📷 Wikipedia: Sumatriptan · Source
Sumatriptan 1A Pharma 50 mg - Tabletten 50 mg (Tablette)
📷 Wikipedia: Sumatriptan · Source
Sumatriptan 1A Pharma 50 mg tablets are currently restricted from parallel export due to manufacturing capacity shortages. The affected packs are the 6-tablet box, which has been unavailable since June 8, 2026, and the 2-tablet box, which remains available.
⚠️
Shortage ongoing
SUMATRIPTAN SUCCINAT is currently in short supply in AT.
📈 Timeline
2 days active so far
June 9, 2026 June 10, 2026

What is this? Sumatriptan is a medicine used to treat migraine headaches. It comes as tablets.

What's happening? Some packs of this medicine are not available right now. Only smaller packs are still in stock.

Does this affect me? If you take this medicine, you may have trouble finding it. Check with your pharmacist.

What should I do? Ask your pharmacist or doctor for advice before changing how you take your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
SUMATRIPTAN SUCCINAT
Agency-published detail

🚫 Parallel export ban active · ATC: N02CC01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 6 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-06-08] · 2 Stück Schachtel, Blisterpackung [verfügbar]

First published
June 8, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 1 week ago

Imigran 6 mg/0,5 ml - Spritzampullen 6 mg/0,5 ml (Injektionslösung)

Imigran 6 mg/0.5 ml injection solution ampoules are subject to a parallel export ban.
Low AT 2 weeks ago

Sumanet 85 mg/500 mg Filmtabletten 85 mg/500 mg (Filmtablette)

Parallel export is banned for this medicine. Shortages in production have caused supply issues.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Sumatriptan 1A Pharma 50 mg - Tabletten 50 mg (Tablette). Sumatriptan 1A Pharma 50 mg tablets are currently restricted from parallel export due to manufacturing capacity shortages. The affected packs are the 6-tablet box, which has been unavailable since June 8, 2026, and the 2-tablet box, which remains available.
▸ When was this alert issued?
This alert was issued on June 8, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.